Psychedelic Therapies Show Promise in Treating Depression
TL;DR Summary
A drug related to the psychedelic DMT, BPL-003, shows promising results in treating difficult depression, boosting biotech stocks and indicating a potential shift in FDA attitudes towards psychedelic medicines for mental health conditions.
- A Promising Depression Drug Works. Psychedelics Are Back. Barron's
- Beckley and atai Leadership Unpack Phase 2b Data, Take Aim at GH’s Dosing Model Psychedelic Alpha
- Psychedelic nasal spray shows promise against depression Financial Times
- Psychedelic therapy shows promise in mid-stage study in treatment-resistant depression STAT
- Atai and Beckley, set to merge, reveal study success for psychedelic drug BioPharma Dive
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 3 min read
Condensed
94%
598 → 33 words
Want the full story? Read the original article
Read on Barron's